Together with the downregulation of UBE3A by Aβ oligomers, we propose that the potential regulation of APP by UBE3A reduces the Aβ production, which is dampened in the AD condition and further deteriorated by the accumulation of Aβ. This evidence concerns the gene UBE3A and Alzheimer disease.